相似文献
1
A Call to Arms: Quest for a Cryptococcal Vaccine.
Trends Microbiol. 2018 May;26(5):436-446. doi: 10.1016/j.tim.2017.10.002. Epub 2017 Nov 2.
2
Vaccination with Recombinant Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.
mBio. 2017 Nov 28;8(6):e01872-17. doi: 10.1128/mBio.01872-17.
3
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
mBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15.
4
A Heat-Killed Mutant Strain Induces Host Protection against Multiple Invasive Mycoses in a Murine Vaccine Model.
mBio. 2019 Nov 26;10(6):e02145-19. doi: 10.1128/mBio.02145-19.
5
Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
mBio. 2015 Oct 6;6(5):e01433-15. doi: 10.1128/mBio.01433-15.
6
Feasibility and prospects for a vaccine to prevent cryptococcosis.
Med Mycol. 2005 Dec;43(8):667-80. doi: 10.1080/13693780500448230.
7
Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.
Vaccine. 2020 Jan 16;38(3):620-626. doi: 10.1016/j.vaccine.2019.10.051. Epub 2019 Nov 4.
8
Methodology for Anti-Cryptococcal Vaccine Development.
Methods Mol Biol. 2017;1625:129-140. doi: 10.1007/978-1-4939-7104-6_10.
9
Vaccine Strategies for Cryptococcus neoformans.
Methods Mol Biol. 2024;2775:411-422. doi: 10.1007/978-1-0716-3722-7_28.
10
Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model.
mBio. 2019 Apr 2;10(2):e02909-18. doi: 10.1128/mBio.02909-18.
引用本文的文献
1
infections: aspartyl protease potential to improve outcome in susceptible hosts.
mBio. 2024 Nov 13;15(11):e0273324. doi: 10.1128/mbio.02733-24. Epub 2024 Oct 23.
2
Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections.
Vaccines (Basel). 2024 Aug 28;12(9):981. doi: 10.3390/vaccines12090981.
3
Inhibition of host 5-lipoxygenase reduces overexuberant inflammatory responses and mortality associated with meningoencephalitis.
mBio. 2024 Sep 11;15(9):e0148324. doi: 10.1128/mbio.01483-24. Epub 2024 Jul 31.
4
Adjuvant ArtinM favored the host immunity against infection in C57BL/6 mice.
Immunotherapy. 2024;16(11):733-748. doi: 10.1080/1750743X.2024.2360384. Epub 2024 Jun 28.
5
Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi.
Arch Microbiol. 2024 Jun 8;206(7):293. doi: 10.1007/s00203-024-04010-7.
6
Semisynthetic Glycoconjugate Vaccine Candidates against .
ACS Infect Dis. 2024 Jun 14;10(6):2089-2100. doi: 10.1021/acsinfecdis.4c00094. Epub 2024 May 31.
7
Chitosan-Deficient Cryptococcus as Whole-Cell Vaccines.
Methods Mol Biol. 2024;2775:393-410. doi: 10.1007/978-1-0716-3722-7_27.
8
Semi-synthetic glycoconjugate vaccine candidate against .
bioRxiv. 2024 Feb 3:2024.02.02.578725. doi: 10.1101/2024.02.02.578725.
9
A consensus structural motif for the capsular polysaccharide of by NMR/MD.
Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2322413121. doi: 10.1073/pnas.2322413121. Epub 2024 Feb 9.
10
Dendritic Cells: Multifunctional Roles in Host Defenses to Infections.
J Fungi (Basel). 2023 Oct 26;9(11):1050. doi: 10.3390/jof9111050.
本文引用的文献
1
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
Lancet Infect Dis. 2017 Aug;17(8):873-881. doi: 10.1016/S1473-3099(17)30243-8. Epub 2017 May 5.
2
Evaluation of trained immunity by β-1, 3 (d)-glucan on murine monocytes in vitro and duration of response in vivo.
Immunol Cell Biol. 2017 Aug;95(7):601-610. doi: 10.1038/icb.2017.13. Epub 2017 Feb 23.
3
Is a Primary Pathogen?
J Fungi (Basel). 2015;1(2):154-167. doi: 10.3390/jof1020154. Epub 2015 Jul 29.
4
Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
mBio. 2016 May 10;7(3):e00547-16. doi: 10.1128/mBio.00547-16.
5
Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.
PLoS One. 2016 Apr 15;11(4):e0153853. doi: 10.1371/journal.pone.0153853. eCollection 2016.
6
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
mBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15.
7
Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
mBio. 2015 Oct 6;6(5):e01433-15. doi: 10.1128/mBio.01433-15.
8
The Cnes2 locus on mouse chromosome 17 regulates host defense against cryptococcal infection through pleiotropic effects on host immunity.
Infect Immun. 2015 Dec;83(12):4541-54. doi: 10.1128/IAI.00697-15. Epub 2015 Sep 14.
9
Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265.
Microbes Infect. 2016 Jan;18(1):57-67. doi: 10.1016/j.micinf.2015.08.017. Epub 2015 Sep 11.
10
STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
Infect Immun. 2015 Dec;83(12):4513-27. doi: 10.1128/IAI.00935-15. Epub 2015 Sep 8.
Zotero 插件